This test is most useful if any of these apply to you.
Your mouth and upper airway are in constant contact with microbes, viruses, and irritants. The main reason most of that traffic never turns into infection is a single class of antibody coating those surfaces with quiet, mechanical efficiency.
Salivary sIgA (secretory immunoglobulin A) is one of the more direct readouts of how well that barrier is working. Levels track with susceptibility to colds and dental disease, shift with stress and overtraining, and run high in several autoimmune conditions, giving you a non-invasive view of mucosal immunity that no blood panel captures the same way.
sIgA is the dominant antibody in saliva. Structurally, it is two IgA antibodies stitched together with a small chain and wrapped in a protective protein called the secretory component, which keeps it stable in the harsh environment of the mouth. Plasma cells in your salivary glands produce it, and the lining cells of those glands ferry it into your saliva, where it binds incoming pathogens before they can attach to tissue.
Labs report two related numbers. Concentration tells you how much sIgA is in a given volume of saliva. Secretion rate, which combines concentration with how fast you are producing saliva, more accurately reflects how much antibody is actually reaching mucosal surfaces. Where possible, secretion rate is the more meaningful number.
Lower salivary sIgA tracks with more frequent upper airway infections, particularly in people pushing their physical limits. In American college football players followed across a season, a fall in sIgA secretion rate was the most useful single biomarker for predicting upper respiratory tract infections. In elite rugby players, salivary sIgA levels were able to flag a meaningful change in short-term infection risk.
A meta-analysis of studies in children and adults found that people with dental caries had significantly lower salivary sIgA than caries-free controls, especially in children. The same antibody that fends off respiratory viruses also helps keep cavity-causing bacteria from settling onto enamel.
After COVID-19 vaccination with messenger RNA shots, salivary IgA rises but is highly variable. People with weaker salivary anti-Spike IgA responses were more likely to develop breakthrough infections despite similar blood antibody levels, suggesting that what is happening at your mucosal barrier matters even when your blood looks protected.
One long-term finding comes from the West of Scotland Twenty-07 Study, which followed 639 adults for roughly 19 years. Higher salivary sIgA secretion rate at baseline was associated with a lower risk of dying from cancer over the follow-up period. The link held after adjusting for age, sex, and health behaviors, pointing toward sIgA as a marker of broad immune resilience rather than only an oral-defense number.
Persistently elevated sIgA is not automatically good. In systemic lupus erythematosus, an autoimmune disease that affects multiple organs, total salivary IgA and the IgA1 subtype have been reported to be higher than in healthy controls, and salivary IgA tracks with serum markers of disease activity.
In rheumatoid arthritis, the picture is more specific. Total sIgA tends to be normal, but a subgroup of patients produces salivary IgA antibodies targeting citrullinated proteins (ACPA, or anti-citrullinated protein antibodies). Among rheumatoid arthritis patients in one study, those with detectable salivary ACPA had higher inflammation markers, more tender joints, and worse overall disease activity, supporting the idea that mucosal immune activity in the mouth may feed the joint disease.
In Crohn's disease, higher salivary IgA against periodontitis-associated bacteria has been linked to disease status, hinting that the oral mucosal immune system is part of the larger inflammatory bowel picture.
This is not a simple "higher is better" or "lower is worse" marker. Low secretion rates suggest a thinned-out mucosal defense and track with more infections, cavities, and worse long-term cancer outcomes. Persistently high levels can reflect a robust response to recent infection or vaccination, but they can also reflect chronic mucosal immune activation, as seen in lupus, rheumatoid arthritis, Crohn's disease, and post-COVID-19 mucosal changes. Context matters: a number is only meaningful alongside your symptoms, your other labs, and your trend over time.
Salivary sIgA is one of the more direct biological readouts of the stress-immune connection. Acute stress (a tough work presentation, a hard conversation) briefly pushes sIgA up, then it returns to baseline within minutes. Sustained psychological distress goes the other way. A study of 113 adults found that higher perceived stress, loneliness, and depression were associated with lower salivary IgA1 and lower IgA1 to secretory component ratios, consistent with a slow depletion of available antibody.
A university exam period was enough to drop salivary IgA secretion rates in 58 students while their cortisol climbed, demonstrating that real-life sustained stress, not just laboratory stressors, can weaken mucosal immunity over weeks.
Healthy older adults tend to show higher serum and salivary IgA than younger adults, reflecting an age-related shift in mucosal immune output. But this background rise does not protect every older person equally, which is why secretion rate, trends over time, and clinical context still matter more than a single absolute number at any age.
Salivary sIgA is highly variable. Within the same person, day-to-day fluctuations can reach 40 to 50 percent, and between-person differences often exceed 60 percent. A single value is best treated as a snapshot, not a diagnosis.
Because biological noise around any single sIgA reading is substantial, your trend over weeks and months carries more weight than any one collection. In elite athletes, a decrease in relative sIgA over three weeks was a better predictor of an oncoming upper respiratory infection than the absolute number on any one day. The same logic applies to anyone using sIgA to gauge how stress, training load, or a new daily habit is affecting their immune barrier.
A reasonable approach: get a baseline, retest in 8 to 12 weeks if you are changing training, sleep, stress management, or diet, and then at least annually thereafter. Always collect at the same time of day, ideally within an hour of waking, before brushing your teeth or eating, and on a day without intense exercise in the prior 24 hours.
A single low value should not send you down a rabbit hole. First, retest under standardized conditions and look at the trend. If your secretion rate is persistently low and you are getting frequent colds, dental issues, or are training hard, consider checking serum total IgA to rule out selective IgA deficiency, alongside a basic immune workup (complete blood count with differential, vitamin D, and ferritin) and an honest look at sleep, stress, and training load.
A persistently elevated salivary IgA, especially combined with joint pain, fatigue, gastrointestinal symptoms, or a rash, is a different conversation. Pair it with a more targeted autoimmune workup (anti-nuclear antibody screen, rheumatoid factor, anti-citrullinated protein antibodies, and disease-specific markers) and discuss the pattern with a rheumatologist or immunologist if those return abnormal. The goal is to interpret sIgA in the context of the larger immune picture, not in isolation.
Evidence-backed interventions that affect your Salivary sIgA level
Secretory IgA is best interpreted alongside these tests.
Secretory IgA is included in these pre-built panels.